Candel Therapeutics Stock In The News
| CADL Stock | USD 8.75 0.81 10.20% |
Our overall analysis of Candel Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Candel Therapeutics. The specific impact of Candel Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Candel Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Candel Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Candel Therapeutics Backtesting and Candel Therapeutics Hype Analysis. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.
Candel |
Candel Therapeutics Today Top News and Investor Outlook
Candel Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Candel and other traded companies coverage with news coverage. We help investors stay connected with Candel headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Candel Stock performance. Please note that trading solely based on the Candel Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Candel Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Candel earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Candel Therapeutics that are available to investors today. That information is available publicly through Candel media outlets and privately through word of mouth or via Candel internal channels. However, regardless of the origin, that massive amount of Candel data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Candel Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Candel Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Candel Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Candel Therapeutics alpha.
Candel Largest EPS Surprises
Earnings surprises can significantly impact Candel Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-12 | 2021-09-30 | -0.29 | -0.26 | 0.03 | 10 | ||
2023-08-10 | 2023-06-30 | -0.3 | -0.34 | -0.04 | 13 | ||
2023-05-11 | 2023-03-31 | -0.35 | -0.3 | 0.05 | 14 | ||
2022-11-10 | 2022-09-30 | -0.35 | -0.3 | 0.05 | 14 | ||
2022-08-05 | 2022-06-30 | -0.41 | -0.32 | 0.09 | 21 | ||
2023-11-09 | 2023-09-30 | -0.19 | -0.31 | -0.12 | 63 |
Candel Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Candel Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
13th of March 2025
Candel Therapeutics Issues Quarterly Earnings Results at thelincolnianonline.com
25th of February 2025
Candel Therapeutics Announces Positive Final Survival Data from Randomized Controlled Phas... at gurufocus.com
20th of February 2025
Major Indexes Falter Dow Drops Over 550 Points at talkmarkets.com
13th of February 2025
Trend Tracker for - Stock Traders Daily at news.google.com
7th of February 2025
FMR LLCs Strategic Acquisition of Candel Therapeutics Shares at gurufocus.com
10th of January 2025
Candel therapeutics CMO sells 88,749 in stock - Investing.com at news.google.com
6th of January 2025
Institutions profited after Candel Therapeutics, Inc.s market cap rose US41m last week but... at simplywall.st
26th of December 2024
Disposition of 50000 shares by Aguilar-cordova Estuardo of Candel Therapeutics at 9.01 sub... at MacroaxisInsider
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Candel Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Candel Therapeutics' short interest history, or implied volatility extrapolated from Candel Therapeutics options trading.
Check out Candel Therapeutics Backtesting and Candel Therapeutics Hype Analysis. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.